1. Home
  2. IMRX vs FUND Comparison

IMRX vs FUND Comparison

Compare IMRX & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • FUND
  • Stock Information
  • Founded
  • IMRX 2008
  • FUND 1988
  • Country
  • IMRX United States
  • FUND Canada
  • Employees
  • IMRX N/A
  • FUND N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • FUND Investment Managers
  • Sector
  • IMRX Health Care
  • FUND Finance
  • Exchange
  • IMRX Nasdaq
  • FUND Nasdaq
  • Market Cap
  • IMRX 232.9M
  • FUND 243.4M
  • IPO Year
  • IMRX 2021
  • FUND N/A
  • Fundamental
  • Price
  • IMRX $8.07
  • FUND $8.15
  • Analyst Decision
  • IMRX Strong Buy
  • FUND
  • Analyst Count
  • IMRX 4
  • FUND 0
  • Target Price
  • IMRX $13.75
  • FUND N/A
  • AVG Volume (30 Days)
  • IMRX 1.3M
  • FUND 32.5K
  • Earning Date
  • IMRX 11-12-2025
  • FUND 01-01-0001
  • Dividend Yield
  • IMRX N/A
  • FUND 6.64%
  • EPS Growth
  • IMRX N/A
  • FUND N/A
  • EPS
  • IMRX N/A
  • FUND 0.93
  • Revenue
  • IMRX N/A
  • FUND N/A
  • Revenue This Year
  • IMRX N/A
  • FUND N/A
  • Revenue Next Year
  • IMRX N/A
  • FUND N/A
  • P/E Ratio
  • IMRX N/A
  • FUND $8.33
  • Revenue Growth
  • IMRX N/A
  • FUND N/A
  • 52 Week Low
  • IMRX $1.10
  • FUND $6.75
  • 52 Week High
  • IMRX $9.37
  • FUND $8.47
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 69.91
  • FUND 51.98
  • Support Level
  • IMRX $7.82
  • FUND $8.24
  • Resistance Level
  • IMRX $8.85
  • FUND $8.43
  • Average True Range (ATR)
  • IMRX 0.75
  • FUND 0.09
  • MACD
  • IMRX 0.19
  • FUND -0.03
  • Stochastic Oscillator
  • IMRX 69.91
  • FUND 12.47

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

Share on Social Networks: